Treatment of Group B Streptococcus Urinary Tract Infection
For Group B Streptococcus (GBS) UTI, treat with penicillin or ampicillin as first-line therapy, with nitrofurantoin, cephalosporins, or trimethoprim-sulfamethoxazole as alternatives based on susceptibility testing.
Treatment Approach by Clinical Context
Non-Pregnant Patients
For symptomatic GBS UTI in non-pregnant patients, the treatment follows standard UTI principles with organism-specific considerations:
First-line options:
- Ampicillin or Amoxicillin (high urinary concentrations overcome resistance) 1
- Penicillin (narrow spectrum, preferred when susceptible)
- Duration: 7 days for uncomplicated cystitis, 7-14 days for complicated UTI 2
Alternative agents (based on susceptibility):
- Nitrofurantoin 100 mg PO every 6 hours 1
- Cephalothin (100% susceptibility reported) 3
- Norfloxacin (96.9% susceptibility) 3
- Trimethoprim-sulfamethoxazole - though resistance rates of 68.9% have been reported, so use only if susceptible 4, 3
Avoid:
Pregnant Patients
The management differs significantly in pregnancy, where GBS bacteriuria has specific implications:
Key principle: Any level of GBS bacteriuria in pregnancy (regardless of colony count) indicates heavy colonization and requires intrapartum antibiotic prophylaxis, NOT antepartum treatment 6, 7.
Management algorithm:
- Do NOT treat GBS bacteriuria during pregnancy with oral antibiotics - this is ineffective at eliminating carriage and may cause harm 6
- Document GBS-positive status - no need for repeat screening in third trimester 7
- Provide intrapartum prophylaxis at time of labor or membrane rupture 7
Intrapartum prophylaxis regimens 8:
- Penicillin G: 5 million units IV initial dose, then 2.5-3.0 million units IV every 4 hours until delivery (preferred)
- Ampicillin: 2 g IV initial dose, then 1 g IV every 4 hours until delivery (alternative)
- For penicillin allergy (non-anaphylactic): Cefazolin 2 g IV initial, then 1 g IV every 8 hours
- For severe penicillin allergy: Clindamycin 900 mg IV every 8 hours (if susceptible) OR Vancomycin 1 g IV every 12 hours
Exception: If GBS bacteriuria presents with symptomatic UTI (≥100,000 CFU/mL with symptoms), treat the acute infection appropriately, then provide intrapartum prophylaxis 7.
Important Clinical Nuances
Progression Risk
GBS UTI has markedly lower progression to pyelonephritis (1.1%) compared to E. coli (15.6%), though obstetric outcomes remain similar 9. This lower virulence doesn't justify withholding appropriate treatment but provides reassurance about disease trajectory.
Susceptibility Patterns
GBS demonstrates excellent susceptibility to beta-lactams (ampicillin 96%, cephalothin 100%) but concerning resistance to macrolides and tetracyclines 3. Always obtain culture and susceptibility testing to guide therapy, particularly given the 33.6% multidrug resistance rate reported in recent studies 5.
Catheter-Associated UTI
For catheter-associated GBS UTI, follow standard CAUTI principles: remove or exchange catheter if possible, treat for 5-7 days with appropriate antibiotics based on susceptibility 10.
Common Pitfalls to Avoid
- Do not treat asymptomatic GBS bacteriuria in pregnancy with oral antibiotics - this represents colonization requiring only intrapartum prophylaxis 6
- Do not use erythromycin or clindamycin empirically without susceptibility testing - resistance rates exceed 25-36% 3, 5
- Do not repeat GBS screening if bacteriuria documented - patient is presumed colonized 7
- Do not delay intrapartum prophylaxis - optimal protection requires ≥4 hours before delivery 8
The evidence strongly supports beta-lactam antibiotics as the cornerstone of GBS UTI treatment, with pregnancy requiring a distinct management approach focused on intrapartum rather than antepartum intervention.